Abstract
Loss of Mdm2 or Mdm4 leads to embryo lethal phenotypes that are p53-dependent. To determine whether Mdm2 and Mdm4 inhibit p53 function redundantly in a more restricted cell type, conditional alleles were crossed to a neuronal specific Cre transgene to delete Mdm2 and Mdm4 in the CNS. Mice lacking Mdm2 in the CNS developed hydranencephaly at embryonic day 12.5 due to apoptosis, whereas Mdm4 deletion showed a proencephaly phenotype at embryonic day 17.5 because of cell cycle arrest and apoptosis. The deletion of both genes, strikingly, contributed to an even earlier and more severe CNS phenotype. Additionally, Mdm2 and Mdm4 had a gene dosage effect, because loss of three of the four Mdm alleles also showed a more accelerated CNS phenotype than deletion of either gene alone. All phenotypes were rescued by deletion of p53 . Thus, these in vivo data demonstrate the importance of Mdm4 independent of Mdm2 in inhibition of p53.
References
43
Referenced
117
- K. H. Vousden, C. Prives Cell 120, 7–10 (2005). / Cell by Vousden K. H. (2005)
10.1016/S0027-5107(99)00162-1
10.1016/0092-8674(92)90644-R
10.1002/j.1460-2075.1996.tb00919.x
10.1016/S0092-8674(03)00193-4
10.1038/nature02514
10.1016/S0378-1119(99)00487-4
10.1038/sj.onc.1204533
10.1128/MCB.24.13.5835-5843.2004
10.1038/378203a0
10.1038/378206a0
10.1038/ng714
- R. A. Finch, D. B. Donoviel, D. Potter, M. Shi, A. Fan, D. D. Freed, C. Y. Wang, B. P. Zambrowicz, R. Ramirez-Solis, A. T. Sands, et al. Cancer Res 62, 3221–3225 (2002). / Cancer Res by Finch R. A. (2002)
10.1128/MCB.22.15.5527-5538.2002
- A. Chavez-Reyes, J. M. Parant, L. L. Amelse, R. M. de Oca Luna, S. J. Korsmeyer, G. Lozano Cancer Res 63, 8664–8669 (2003). / Cancer Res by Chavez-Reyes A. (2003)
10.1038/387296a0
10.1016/S0014-5793(97)01480-4
10.1038/387299a0
10.1074/jbc.275.12.8945
10.1128/MCB.20.3.1001-1007.2000
10.1038/sj.onc.1204615
10.1093/embo-reports/kve227
10.1038/sj.onc.1202281
10.1074/jbc.274.53.38189
10.1016/S0014-5793(99)00254-9
10.1002/gene.10066
10.1128/MCB.26.1.192-198.2006
10.1126/science.280.5366.1089
10.1242/dev.121.7.2165
10.1038/nn1172
10.1006/geno.1996.0210
10.1016/S0925-4773(98)00074-4
10.1016/S0896-6273(01)00374-9
10.1038/5007
10.1074/jbc.M003496200
10.1038/sj.onc.1203468
10.1073/pnas.2030930100
10.1074/jbc.M213034200
10.1128/MCB.23.15.5113-5121.2003
10.1038/ng1282
10.1242/dev.120.11.3173
10.1128/MCB.24.20.8884-8894.2004
10.1016/j.cell.2005.09.029
Dates
Type | When |
---|---|
Created | 19 years, 6 months ago (Feb. 21, 2006, 11:03 p.m.) |
Deposited | 3 years, 4 months ago (April 12, 2022, 2:08 p.m.) |
Indexed | 1 month ago (July 23, 2025, 7:59 a.m.) |
Issued | 19 years, 6 months ago (Feb. 21, 2006) |
Published | 19 years, 6 months ago (Feb. 21, 2006) |
Published Online | 19 years, 6 months ago (Feb. 21, 2006) |
Published Print | 19 years, 6 months ago (Feb. 28, 2006) |
@article{Xiong_2006, title={Synergistic roles of Mdm2 and Mdm4 for p53 inhibition in central nervous system development}, volume={103}, ISSN={1091-6490}, url={http://dx.doi.org/10.1073/pnas.0508500103}, DOI={10.1073/pnas.0508500103}, number={9}, journal={Proceedings of the National Academy of Sciences}, publisher={Proceedings of the National Academy of Sciences}, author={Xiong, Shunbin and Van Pelt, Carolyn S. and Elizondo-Fraire, Ana C. and Liu, Geng and Lozano, Guillermina}, year={2006}, month=feb, pages={3226–3231} }